Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day | NASDAQ:IMUX

Proactive InvestorsMay 30 01:42

Immunic to Participate in Industry and Scientific Conferences in June

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic...

PR NewswireMay 28 05:30

Immunic Inc increases hybrid shelf offering from $250 million to $412.3 million — SEC filing

Immunic Inc increases hybrid shelf offering from $250 million to $412.3 million — SEC filing

Zhitong FinanceMay 24 15:19

Express News | Immunic Inc Raises Size of Mixed Shelf Offering to $412.3 Mln From $250 Mln - SEC Filing

BreakingsMay 24 15:18

Hold Rating on Immunic Amidst Ongoing Vido Clinical Trials and Financial Outlook

TipRanksMay 10 00:26

Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 09:23